Spire Healthcare Group PLC (SPI) Given Average Recommendation of “Hold” by Brokerages

Spire Healthcare Group PLC (LON:SPI) has been assigned an average recommendation of “Hold” from the eight analysts that are presently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and three have issued a buy recommendation on the company. The average 1 year target price among brokerages that have issued a report on the stock in the last year is GBX 281 ($3.74).

Several research firms have recently issued reports on SPI. JPMorgan Chase & Co. reaffirmed a “neutral” rating and set a GBX 339 ($4.51) price objective on shares of Spire Healthcare Group in a research report on Monday, March 5th. Numis Securities raised Spire Healthcare Group to a “buy” rating and set a GBX 296 ($3.94) price objective for the company in a research report on Friday, March 2nd. Barclays lowered their price objective on Spire Healthcare Group from GBX 270 ($3.59) to GBX 255 ($3.40) and set an “equal weight” rating for the company in a research report on Monday, March 5th. Liberum Capital reaffirmed a “hold” rating and set a GBX 275 ($3.66) price objective on shares of Spire Healthcare Group in a research report on Thursday, March 1st. Finally, Berenberg Bank lowered their price objective on Spire Healthcare Group from GBX 310 ($4.13) to GBX 290 ($3.86) and set a “buy” rating for the company in a research report on Thursday, March 22nd.

Spire Healthcare Group traded up GBX 6 ($0.08), hitting GBX 253.60 ($3.38), during trading hours on Monday, according to MarketBeat Ratings. 1,055,899 shares of the company were exchanged, compared to its average volume of 1,770,000. Spire Healthcare Group has a 52-week low of GBX 206.40 ($2.75) and a 52-week high of GBX 362.10 ($4.82).

In other Spire Healthcare Group news, insider Peter R. Bamford acquired 4,000 shares of the stock in a transaction dated Thursday, June 7th. The stock was acquired at an average cost of GBX 248 ($3.30) per share, with a total value of £9,920 ($13,207.30).

Spire Healthcare Group Company Profile

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It provides a range of integrated surgical, medical, and diagnostic services. The company offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgeries, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat problems; and eye surgery and treatments, family planning, foreign visa medical exams, gastroenterology, general medicine, general surgery, haematology, hand surgery, heart diseases, and kidney disorders.

Analyst Recommendations for Spire Healthcare Group (LON:SPI)

Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply